Antiestrogenic Effects of the Novel Sphingosine Kinase-2 Inhibitor ABC294640
James W. Antoon(Vanderbilt University Medical Center), Barbara S. Beckman(Tulane University)
Cited by 114
Related Papers
Pharmacological inhibition of sphingosine kinase isoforms alters estrogen receptor signaling in human breast cancer
|Journal of Molecular Endocrinology|2011|49
Altered Death Receptor Signaling Promotes Epithelial-to-Mesenchymal Transition and Acquired Chemoresistance
|Scientific Reports|2012|37
Intravenous antibiotics for urinary tract infections in children with neurologic impairment
|Journal of Hospital Medicine|2024|3